JPMorgan Flem Russian Secs PLC
07 January 2003
STOCK EXCHANGE ANNOUNCEMENT
JPMORGAN FLEMING RUSSIAN SECURITIES PLC
Re: Final Asset Values of The Fleming Russia Securities Fund Limited (in
liquidation) and size of new fund
Following the Extraordinary General Meeting of The Fleming Russia Securities
Fund Limited ('the Company') held on 6 December 2002 the Company was placed into
liquidation on 19 December 2002 pursuant to a members' summary winding-up with
Messrs. D Pirouet and B McMahon of PricewaterhouseCoopers being appointed
liquidators of the Company.
Asset Value
As at 10.00 a.m. on 16 December 2002, the calculation time for the valuation of
the Company's assets for the purposes of determining the entitlements of
Shareholders under the Proposals, the Company had net assets of approximately
US$ 161.7 million.
FAVs
Cash FAV - US$ 28.452 million
Rollover FAV - US$ 92.047 million
In Specie FAV - US$ 41.214 million
FINAL ENTITLEMENTS
Cash Entitlement
On 31 December 2002 the liquidators of the Company declared and paid a first
distribution of US$ 17.00 per Participating Share. In a letter sent to all cash
electors on that date it was indicated that due to Russian market settlement
procedures it had not been able to settle all of the trades prior to the date of
the first distribution. As a result it was proposed that a second distribution
would be declared and paid once settlement had been received on the remaining
trades. It is expected that this distribution will be made in early February
2003.
Including the US$ 17.00 paid on 31 December 2002 it is expected that
Shareholders electing for the Cash Option or Shareholders who failed to make a
valid election and who therefore receive cash under the Cash Option will
receive, in aggregate, approximately US$ 20.45 per Participating Share.
Rollover Entitlement
Elections in respect of 4,162,356 Participating Shares were received for the
Rollover Option. As a consequence, 58,835,612 Ordinary Shares in JPMFRS were
issued on 17 December 2002. Participating Shareholders who elected for the
Rollover Option will therefore receive 14.13517056 JPMFRS Shares per
Participating Share.
In Specie Entitlement
Elections in respect of 2,044,275 Participating Shares were received for the In
Specie Option. Participating Shareholders who elected for the In Specie Option
have therefore received assets to the value of US$ 20.16 per Participating
Share.
JPMorgan Fleming Russian Securities plc (JFR.L)
The number of shares in issue is 60,062,612.
The ISIN code for the JPMFRS Ordinary Shares is GB 0032164732
Enquiries
J.P. Morgan Fleming Asset Management (UK) Limited
Robert Peel 020 7742 3422
Craig Cleland 020 7742 3418
David Barron 020 7742 3475
UBS Warburg Ltd.
Nicholas Rucker 020 7568 8574
David Bliss 020 7568 4587
Phil Higgs 020 7568 0960
Paul Harrington 020 7568 4569
Enquiries regarding the register or the crediting of CREST accounts
Lloyds TSB Registrars:
Sue McElhinney 020 7489 3093
David Andrews 020 7489 3059
7 January 2003
For further information, please contact:
Richard Lewis (Company Secretary)
J.P. Morgan Fleming Asset Management (UK) Limited, 020 7742 3477
This information is provided by RNS
The company news service from the London Stock Exchange
*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
Obtains access to the information in a personal capacity;
Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
Please note, this site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about the cookies used on Investegate and how you can manage them, see our Privacy and Cookie Policy
To continue using Investegate, please confirm that you are a private investor as well as agreeing to our Privacy and Cookie Policy & Terms.